Shanghai Henlius Biotech, Inc.
2696Biotechnology
HK$49.06−1.72%As of Oct 30vs prior close
- Market cap
- $2.2B
- P/E (TTM)
- 16.7×
- P/E (FY1)
- 23.9×
- From 52W high
- −41.91%
- EPS (TTM)
- CN¥1.52
- Revenue (LTM)
- CN¥7.4B
- Net margin
- 11.67%
Nomior Score
35
Steady ProfileBottom 21% of the scored universe
Growth35
Quality60
Value45
Momentum28
Resilience41
Growth
+27.52%revenue a year over 3 fiscal years
YE22 CN¥3.2BLTM CN¥7.4B
Connections
Revenue to profitYE25
12% of revenue became net profit, down 2 pts on a year.